| Identification | Back Directory | [Name]
H2N-PEG5-CH2COOH | [CAS]
141282-35-1 | [Synonyms]
Amino-PEG5
141282-35-1
H2N-PEG5-CH2COOH
NH2-PEG5-CH2COOH
Amino-PEG5-CH2COOH
Amino-PEG5-CH2CO2H
AMINE-PEG5-CH2COOH
Amino-PEG5-CH2CO5H
Amino-PEG5-acetic acid
2-(2-{2-[2-(2-amino-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]aceticacid | [Molecular Formula]
C12H25NO7 | [MDL Number]
MFCD27977526 | [MOL File]
141282-35-1.mol | [Molecular Weight]
295.33 |
| Chemical Properties | Back Directory | [Boiling point ]
434.2±40.0 °C(Predicted) | [density ]
1.150±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C, protect from light | [solubility ]
DMSO : 20 mg/mL (67.72 mM; ultrasonic and warming and heat to 60°C) | [form ]
Solid | [pka]
3.39±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Amino-PEG5-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | [Biological Activity]
Amino-PEG5-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | [IC 50]
PEGs | [References]
[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562. |
|
|